Items where authors include "Lamb, A.D."

Article

Cumberbatch, M., North, B., Kealy, R. et al. (12 more authors) (2025) Protocol for a randomised phase 3 trial evaluating the role of Finasteride in active surveillance for men with low and intermediate-risk prostate cancer: the FINESSE study. BMJ Open, 15 (2). e096431. ISSN 2044-6055

Hamdy, F.C. orcid.org/0000-0003-2627-2154, Lamb, A.D. orcid.org/0000-0002-2968-7155, Tullis, I.D.C. orcid.org/0000-0001-5148-0161 et al. (25 more authors) (2024) First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging, 51 (10). pp. 3009-3025. ISSN 1619-7070

Bryant, R.J. orcid.org/0000-0002-8330-9251, Yamamoto, H. orcid.org/0000-0003-0831-9174, Eddy, B. et al. (26 more authors) (2023) Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique. BJU International, 131 (6). pp. 694-704. ISSN 1464-4096

Erickson, A., He, M., Berglund, E. et al. (28 more authors) (2022) Spatially resolved clonal copy number alterations in benign and malignant tissue. Nature, 608 (7922). pp. 360-367. ISSN 0028-0836

Wu, X., Scott, H., Carlsson, S.V. et al. (13 more authors) (2019) Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy. The Prostate, 79 (10). pp. 1079-1089. ISSN 0270-4137

Johnston, T.J., Shaw, G.L., Lamb, A.D. et al. (29 more authors) (2017) Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial. European Urology, 71 (3). pp. 381-388. ISSN 0302-2838